1
|
Demortier J, Vautier M, Chosidow O, Gallay L, Bessis D, Berezne A, Cordel N, Schmidt J, Smail A, Duffau P, Jachiet M, Begon E, Gottlieb J, Chasset F, Graveleau J, Marque M, Cesbron E, Forestier A, Josse S, Kluger N, Beauchêne C, Le Corre Y, Pagis V, Rigolet A, Guillaume-Jugnot P, Authier FJ, Guilain N, Streichenberger N, Leonard-Louis S, Boussouar S, Landon-Cardinal O, Benveniste O, Allenbach Y. Anti-SAE autoantibody in dermatomyositis: original comparative study and review of the literature. Rheumatology (Oxford) 2023; 62:3932-3939. [PMID: 37010495 DOI: 10.1093/rheumatology/kead154] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2022] [Revised: 02/26/2023] [Accepted: 03/10/2023] [Indexed: 04/04/2023] Open
Abstract
OBJECTIVE Among specific autoantibodies in DM, the anti-small ubiquitin-like modifier activating enzyme (SAE) antibody is rare. We aim to describe the clinical characteristics, cancer prevalence, and muscle pathology of anti-SAE-positive DM. METHODS Patients with a diagnosis of DM and sera positive for the anti-SAE antibody were recruited from 19 centres in this retrospective observational study. The available muscular biopsies were reviewed. We conducted a comparison with anti-SAE-negative DM and a review of the literature. RESULTS Of the patients in the study (n = 49), 84% were women. Skin involvement was typical in 96% of patients, with 10% having calcinosis, 18% ulceration and 12% necrosis; 35% presented with a widespread skin rash. Muscular disease affected 84% of patients, with mild weakness [Medical Research Council (MRC) scale 4 (3, 5)], although 39% of patients had dysphagia. Muscular biopsies showed typical DM lesions. Interstitial lung disease was found in 21% of patients, mainly with organizing pneumonia pattern, and 26% of patients showed dyspnoea. Cancer-associated myositis was diagnosed in 16% of patients and was responsible for the majority of deaths, its prevalence being five times that of the general population. IVIG therapy was administered to 51% of the patients during the course of the disease. Comparison with anti-SAE-negative DM (n = 85) showed less and milder muscle weakness (P = 0.02 and P = 0.006, respectively), lower creatinine kinase levels (P < 0.0001) and less dyspnoea (P = 0.003). CONCLUSION Anti-SAE positive DM is a rare subgroup associated with typical skin features but a potentially diffuse rash, a mild myopathy. Interstitial lung disease defines an organizing pneumonia pattern. Cancer associated DM prevalence is five times that of the general population. TRIAL REGISTRATION ClinicalTrials.gov, http://clinicaltrials.gov, NCT04637672.
Collapse
Affiliation(s)
- Juliette Demortier
- Department of Dermatology, Henri Mondor University Hospital, AP-HP, Créteil, France
| | - Mathieu Vautier
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France
| | - Olivier Chosidow
- Department of Dermatology, Henri Mondor University Hospital, Université Paris-Est Créteil, AP-HP, Créteil, France
| | - Laure Gallay
- Department of Internal Medicine and Clinical Immunology, Edouard Herriot University Hospital, Claude Bernard University Lyon1, Lyon, France
| | - Didier Bessis
- Department of Dermatology, University Hospital Center of Montpellier, Montpellier, France
| | - Alice Berezne
- Department of Internal Medicine, CHR Annecy-Genevois, Annecy, France
| | - Nadège Cordel
- Department of Dermatology and Clinical Immunology, Guadeloupe University Hospital, Pointe-à-Pitre, Guadeloupe and Normandie University, UNIROUEN, IRIB, Inserm, U1234, Rouen, France
| | - Jean Schmidt
- Department of Internal Medicine and Clinical Immunology, Amiens-Picardie Nord University Hospital, Amiens, France
| | - Amar Smail
- Department of Internal Medicine and Clinical Immunology, Amiens-Picardie Nord University Hospital, Amiens, France
| | - Pierre Duffau
- Department of Internal Medicine, Saint André, Bordeaux University Hospital, Bordeaux, France
| | - Marie Jachiet
- Department of Dermatology, Saint-Louis Hospital, AP-HP, Paris, France
| | - Edouard Begon
- Department of Dermatology, René Dubos Hospital, Pontoise, France
| | - Jeremy Gottlieb
- Department of Internal Medicine and Clinical Immunology, Bicêtre Hospital, Université Paris-Sud, AP-HP, Le Kremlin-Bicêtre Cedex, France
| | - François Chasset
- Department of Dermatology, Tenon Hospital, Sorbonne Université, AP-HP, Paris, France
| | - Julie Graveleau
- Department of Internal Medicine, CH de St Nazaire, St Nazaire, France
| | - Myriam Marque
- Department of Dermatology, Caremeau Hospital, Nîmes University Hospital, Nîmes, France
| | - Elise Cesbron
- Department of Dermatology, Le Mans Hospital Center, Le Mans, France
| | - Amandine Forestier
- Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Mutualiste, Grenoble, France
| | - Séverine Josse
- Department of Internal Medicine and Clinical Immunology, Dieppe Hospital, Dieppe, France
| | - Nicolas Kluger
- Department of Dermatology, Helsinki University Hospital, Helsinki, Finland
| | | | - Yannick Le Corre
- Department of Dermatology, Angers University Hospital, Angers, France
| | - Valentine Pagis
- Department of Internal Medicine and Clinical Immunology, Beaujon Hospital, AP-HP, Paris, France
| | - Aude Rigolet
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France
| | - Perrine Guillaume-Jugnot
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France
| | - François-Jérôme Authier
- Department of Pathology, Henri-Mondor University Hospital, Institut Mondor de Recherche Biomédicale, INSERM, Centre de Reference pour les Maladies Neuromusculaires of Nord-Est-Île de France, Université Paris-Est Créteil, AP-HP, Créteil, France
| | - Nelly Guilain
- Department of Pathology, Amiens Picardie University Hospital, Amiens, France
| | | | - Sarah Leonard-Louis
- Neuropathology Department, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France
| | - Samia Boussouar
- ICT Cardiothoracic Imaging Unit, Pitié-Salpêtrière Hospital, AP-HP, Sorbonne Université, Paris, France
| | - Océane Landon-Cardinal
- Division of Rheumatology, Centre Hospitalier de l'Université de Montréal (CHUM), CHUM Research Center, Department of Medicine, Université de Montréal, Montréal, Québec, Canada
| | - Olivier Benveniste
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France
| | - Yves Allenbach
- Department of Internal Medicine and Clinical Immunology, Pitié-Salpêtrière University Hospital, Sorbonne Université, AP-HP, Paris, France
| |
Collapse
|
2
|
Aubignat M, Smail A. Skin lesions. Rev Med Interne 2023; 44:619-620. [PMID: 37414675 DOI: 10.1016/j.revmed.2023.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Accepted: 06/11/2023] [Indexed: 07/08/2023]
Affiliation(s)
- M Aubignat
- Department of Neurology and Movement Disorders, Amiens-Picardie University Hospital, CHU d'Amiens-Picardie, 1, rue du Professeur-Christian-Cabrol, 80054 Amiens, France.
| | - A Smail
- Department of Internal Medicine, Amiens-Picardie University Hospital, CHU d'Amiens-Picardie, 1, rue du Professeur-Christian-Cabrol, 80054 Amiens, France
| |
Collapse
|
3
|
Morain M, Chan Sui Ko A, Robert B, Kime A, Tesson J, Smail A, Duhaut P, Karam J. Une vascularite pancréatique. Rev Med Interne 2022. [DOI: 10.1016/j.revmed.2022.10.335] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
|
4
|
Salle V, Attencourt C, Chevalier M, Semeria L, Boulu X, Karam J, Smail A, Schmidt J, Duhaut P, Dernoncourt A. Cutaneous involvement in relapsed multiple myeloma. Clin Case Rep 2022; 10:e6282. [PMID: 36093446 PMCID: PMC9445254 DOI: 10.1002/ccr3.6282] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2022] [Revised: 08/02/2022] [Accepted: 08/05/2022] [Indexed: 11/05/2022] Open
Abstract
Cutaneous involvement in multiple myeloma with extramedullary disease is rare. We report the case of a refractory multiple myeloma patient who developed a cutaneous lesion. Histopathology revealed dermal immature plasma cell infiltrate with a lack of CD138 expression. This cutaneous location was associated with an aggressive clinical course and short survival.
Collapse
Affiliation(s)
- Valéry Salle
- Department of Internal Medicine Amiens University Hospital Amiens France
| | | | - Marion Chevalier
- Department of Internal Medicine Amiens University Hospital Amiens France
| | - Lucile Semeria
- Department of Dermatology Amiens University Hospital Amiens France
| | - Xavier Boulu
- Department of Internal Medicine Amiens University Hospital Amiens France
| | - Jean‐Denis Karam
- Department of Internal Medicine Amiens University Hospital Amiens France
| | - Amar Smail
- Department of Internal Medicine Amiens University Hospital Amiens France
| | - Jean Schmidt
- Department of Internal Medicine Amiens University Hospital Amiens France
| | - Pierre Duhaut
- Department of Internal Medicine Amiens University Hospital Amiens France
| | | |
Collapse
|
5
|
Ly KH, Costedoat-Chalumeau N, Liozon E, Dumonteil S, Ducroix JP, Sailler L, Lidove O, Bienvenu B, Decaux O, Hatron PY, Smail A, Astudillo L, Morel N, Boutemy J, Perlat A, Denes E, Lambert M, Papo T, Cypierre A, Vidal E, Preux PM, Monteil J, Fauchais AL. Diagnostic Value of 18F-FDG PET/CT vs. Chest-Abdomen-Pelvis CT Scan in Management of Patients with Fever of Unknown Origin, Inflammation of Unknown Origin or Episodic Fever of Unknown Origin: A Comparative Multicentre Prospective Study. J Clin Med 2022; 11:jcm11020386. [PMID: 35054081 PMCID: PMC8779072 DOI: 10.3390/jcm11020386] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/05/2022] [Accepted: 01/11/2022] [Indexed: 12/24/2022] Open
Abstract
Fluorodesoxyglucose Positron Emission Tomography (PET/CT) has never been compared to Chest-Abdomen-Pelvis CT (CAPCT) in patients with a fever of unknown origin (FUO), inflammation of unknown origin (IUO) and episodic fever of unknown origin (EFUO) through a prospective and multicentre study. In this study, we investigated the diagnostic value of PET/CT compared to CAPCT in these patients. The trial was performed between 1 May 2008 through 28 February 2013 with 7 French University Hospital centres. Patients who fulfilled the FUO, IUO or EFUO criteria were included. Diagnostic orientation (DO), diagnostic contribution (DC) and time for diagnosis of both imaging resources were evaluated. One hundred and three patients were included with 35 FUO, 35 IUO and 33 EFUO patients. PET/CT showed both a higher DO (28.2% vs. 7.8%, p < 0.001) and DC (19.4% vs. 5.8%, p < 0.001) than CAPCT and reduced the time for diagnosis in patients (3.8 vs. 17.6 months, p = 0.02). Arthralgia (OR 4.90, p = 0.0012), DO of PET/CT (OR 4.09, p = 0.016), CRP > 30 mg/L (OR 3.70, p = 0.033), and chills (OR 3.06, p = 0.0248) were associated with the achievement of a diagnosis (Se: 89.1%, Sp: 56.8%). PET/CT both orients and contributes to diagnoses at a higher rate than CAPCT, especially in patients with FUO and IUO, and reduces the time for diagnosis.
Collapse
Affiliation(s)
- Kim-Heang Ly
- Department of Internal Medicine, Limoges University Hospital, CEDEX, 87042 Limoges, France; (E.L.); (S.D.); (E.V.); (A.-L.F.)
- Correspondence: ; Tel.: +33-55-5055-8076
| | - Nathalie Costedoat-Chalumeau
- AP-HP, Cochin University Hospital, Internal Medicine Department, Referral Centre for Rare Autoimmune and Systemic Diseases, 75014 Paris, France; (N.C.-C.); (N.M.)
| | - Eric Liozon
- Department of Internal Medicine, Limoges University Hospital, CEDEX, 87042 Limoges, France; (E.L.); (S.D.); (E.V.); (A.-L.F.)
| | - Stéphanie Dumonteil
- Department of Internal Medicine, Limoges University Hospital, CEDEX, 87042 Limoges, France; (E.L.); (S.D.); (E.V.); (A.-L.F.)
| | - Jean-Pierre Ducroix
- Department of Internal Medicine, Amiens University Hospital, 80054 Amiens, France; (J.-P.D.); (A.S.)
| | - Laurent Sailler
- Department of Internal Medicine, CHU Toulouse-Purpan, CEDEX, 31059 Toulouse, France; (L.S.); (L.A.)
| | - Olivier Lidove
- Department of Internal Medicine, Groupe Hospitalier Diaconesses-Croix Saint-Simon, 75020 Paris, France;
| | - Boris Bienvenu
- Department of Internal Medicine, Caen University Hospital, CEDEX 9, 14033 Caen, France; (B.B.); (J.B.)
| | - Olivier Decaux
- Department of Internal Medicine CHU de Rennes, 35000 Rennes, France; (O.D.); (A.P.)
| | - Pierre-Yves Hatron
- Department of Internal Medicine, CHU Claude Huriez, 59000 Lille, France; (P.-Y.H.); (M.L.)
| | - Amar Smail
- Department of Internal Medicine, Amiens University Hospital, 80054 Amiens, France; (J.-P.D.); (A.S.)
| | - Léonardo Astudillo
- Department of Internal Medicine, CHU Toulouse-Purpan, CEDEX, 31059 Toulouse, France; (L.S.); (L.A.)
| | - Nathalie Morel
- AP-HP, Cochin University Hospital, Internal Medicine Department, Referral Centre for Rare Autoimmune and Systemic Diseases, 75014 Paris, France; (N.C.-C.); (N.M.)
| | - Jonathan Boutemy
- Department of Internal Medicine, Caen University Hospital, CEDEX 9, 14033 Caen, France; (B.B.); (J.B.)
| | - Antoinette Perlat
- Department of Internal Medicine CHU de Rennes, 35000 Rennes, France; (O.D.); (A.P.)
| | - Eric Denes
- Department of Infectious Diseases, CHU Limoges, CEDEX, 87042 Limoges, France; (E.D.); (A.C.)
| | - Marc Lambert
- Department of Internal Medicine, CHU Claude Huriez, 59000 Lille, France; (P.-Y.H.); (M.L.)
| | - Thomas Papo
- Department of Internal Medicine, Paris Diderot University, Assistance Publique-Hôpitaux de Paris, Bichat Hospital, 75018 Paris, France;
| | - Anne Cypierre
- Department of Infectious Diseases, CHU Limoges, CEDEX, 87042 Limoges, France; (E.D.); (A.C.)
| | - Elisabeth Vidal
- Department of Internal Medicine, Limoges University Hospital, CEDEX, 87042 Limoges, France; (E.L.); (S.D.); (E.V.); (A.-L.F.)
| | - Pierre-Marie Preux
- Centre d’Epidémiologie de Biostatistique et de Méthodologie de la Recherche, Limoges University Hospital, CEDEX, 87042 Limoges, France;
| | - Jacques Monteil
- Department of Nuclear Medicine, Limoges University Hospital, CEDEX, 87042 Limoges, France;
| | - Anne-Laure Fauchais
- Department of Internal Medicine, Limoges University Hospital, CEDEX, 87042 Limoges, France; (E.L.); (S.D.); (E.V.); (A.-L.F.)
| |
Collapse
|
6
|
Demortier J, Vautier M, Chosidow O, Gallay L, Bessis D, Berezne A, Cordel N, Schmidt J, Smail A, Duffau P, Jachiet M, Gottlieb J, Chasset F, Guilain N, Streichenberger N, Léonard-Louis S, Authier J, Boussouar S, Benveniste O, Allenbach Y. Dermatomyosite à anticorps anti-SAE: étude descriptive et comparative à un groupe de dermatomyosites SAE-négatives. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.10.202] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
7
|
Chan Sui Ko A, Pater F, Metzelard M, Smail A, Adjodah C, Schmidt J. Des lésions cutanées à rendre marteau ! Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.10.095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
8
|
Mekaouche F, Oukil L, Seddiki M, Boudia F, Fetati H, Memou A, Smail A, Tachma A, Haouati F, Zerdoumi F, Toumi H. Évaluation de l’observance thérapeutique chez les insuffisants rénaux chroniques. Nephrol Ther 2021. [DOI: 10.1016/j.nephro.2021.07.191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
9
|
Metzelard M, Ullmer A, Schmidt J, Salle V, Smail A, Brault C, Duhaut P. Indice de masse corporelle syndrome inflammatoire et maladies autoimmunes. Rev Med Interne 2021. [DOI: 10.1016/j.revmed.2021.03.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
10
|
Aubignat M, Schmidt J, Smail A, Duhaut P, Salle V. Quelle place pour la recherche des anticorps de spécificités étendues (prothrombine, phosphatidyléthanolamine et annexine V) dans le syndrome des antiphospholipides ? Étude rétrospective sur 95 patients. Rev Med Interne 2020. [DOI: 10.1016/j.revmed.2020.10.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
11
|
Aubignat M, Smail A. [Hypercalcemia and bone tumors]. Rev Prat 2020; 70:990. [PMID: 33739759] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/12/2023]
Affiliation(s)
| | - Amar Smail
- Service de médecine interne, CHU Amiens-Picardie, Amiens, France
| |
Collapse
|
12
|
Blanchet B, Jallouli M, Allard M, Ghillani-Dalbin P, Galicier L, Aumaître O, Chasset F, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Le Thi Huong D, Asli B, Kahn JE, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Leroux G, Cohen-Bittan J, Sellam J, Mariette X, Goulvestre C, Hulot JS, Amoura Z, Vidal M, Piette JC, Jourde-Chiche N, Costedoat-Chalumeau N. Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence. Arthritis Res Ther 2020; 22:223. [PMID: 32977856 PMCID: PMC7517694 DOI: 10.1186/s13075-020-02291-z] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Accepted: 08/07/2020] [Indexed: 12/26/2022] Open
Abstract
Background Hydroxychloroquine (HCQ) levels can be measured in both serum and whole blood. No cut-off point for non-adherence has been established in serum nor have these methods ever been compared. The aims of this study were to compare these two approaches and determine if serum HCQ cut-off points can be established to identify non-adherent patients. Methods HCQ levels were measured in serum and whole blood from 573 patients with systemic lupus erythematosus (SLE). The risk factors for active SLE (SLEDAI score > 4) were identified by multiple logistic regression. Serum HCQ levels were measured in 68 additional patients known to be non-adherent, i.e. with whole-blood HCQ < 200 ng/mL. Results The mean (± SD) HCQ levels were 469 ± 223 ng/mL in serum and 916 ± 449 ng/mL in whole blood. The mean ratio of serum/whole-blood HCQ levels was 0.53 ± 0.15. In the multivariate analysis, low whole-blood HCQ levels (P = 0.023), but not serum HCQ levels, were independently associated with active SLE. From the mean serum/whole-blood level ratio, a serum HCQ level of 106 ng/mL was extrapolated as the corresponding cut-off to identify non-adherent patients with a sensitivity of 0.87 (95% CI 0.76–0.94) and specificity of 0.89 (95% CI 0.72–0.98). All serum HCQ levels of patients with whole-blood HCQ below the detectable level (< 20 ng/mL) were also undetectable (< 20 ng/mL). Conclusions These data suggest that whole blood is better than serum for assessing the pharmacokinetic/pharmacodynamic relation of HCQ. Our results support the use of serum HCQ levels to assess non-adherence when whole blood is unavailable.
Collapse
Affiliation(s)
- Benoit Blanchet
- AP-HP, Hôpital Cochin, Biologie du médicament - Toxicologie, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.,UMR8038 CNRS, U1268 INSERM, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
| | - Moez Jallouli
- Service de Médecine interne, Hôpital Hédi Chaker, Sfax, Tunisie
| | - Marie Allard
- Université Paris-Diderot, Sorbonne Paris-Cité, F-75205, Paris, France.,AP-HP, Hôpital Bichat Claude-Bernard, service de médecine interne, 46 rue Henri-Huchard, 75018, Paris, France
| | - Pascale Ghillani-Dalbin
- AP-HP, Hôpital Pitié-Salpêtrière, Département d'immunologie, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Lionel Galicier
- Université Paris Diderot, Sorbonne Paris Cité, Paris, France.,AP-HP, Hôpital Saint Louis, service d'immunologie clinique, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - Olivier Aumaître
- Université de Clermont-Ferrand, 63003, Clermont-Ferrand, France.,CHU Clermont-Ferrand, Hôpital Gabriel Montpied, service de médecine interne, 58 rue Montalembert, 63003, Clermont-Ferrand cedex1, France
| | - François Chasset
- UPMC, Université Paris 6, Paris, France.,AP-HP, Hôpital Tenon, service de dermatologie allergologie, 4 rue de la Chine, 75020, Paris, France
| | - Véronique Le Guern
- AP-HP, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares, service de médecine interne, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France
| | - Frédéric Lioté
- Université de Paris, F-75205, Paris, France.,AP-HP, Hôpital Lariboisière, service de rhumatologie, DMU Locomotion, 2 rue Ambroise Paré, 75010, Paris, France
| | - Amar Smail
- CHU Amiens, Hôpital Nord, service de médecine interne, Place Victor Pauchet, 80000, Amiens, France
| | - Nicolas Limal
- AP-HP, Hôpital Henri Mondor, service de médecine interne, 51 avenue du Maréchal de Tassigny, 94000, Créteil, France
| | - Laurent Perard
- Centre Hospitalier Saint Joseph Saint Luc, service de médecine interne, 20 quai Claude Bernard, 69007, Lyon, France
| | - Hélène Desmurs-Clavel
- Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, service de médecine interne, 5 place d'Arsonval, 69003, Lyon, France
| | - Du Le Thi Huong
- UPMC, Université Paris 6, Paris, France.,AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence pour le Lupus Systémique et le syndrome des Antiphospholipides, service de médecine interne, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Bouchra Asli
- Université Paris Diderot, Sorbonne Paris Cité, Paris, France.,AP-HP, Hôpital Saint Louis, service d'immunologie clinique, 1 avenue Claude Vellefaux, 75010, Paris, France
| | - Jean-Emmanuel Kahn
- Servie de Médecine Interne, Hôpital Ambroise Paré, Université Paris Saclay, 9 Avenue Charles de Gaulle, 92104, Boulogne-Billancourt, France
| | - Laurent Sailler
- Université Paul-Sabatier, Toulouse, France.,CHU Toulouse, Hôpital Purpan, Service de Médecine Interne, Place Dr Baylac, F-31059, Toulouse, France
| | - Félix Ackermann
- Hôpital Foch, Service de médecine interne, 92150, Suresnes, France
| | - Thomas Papo
- Université Paris-Diderot, Sorbonne Paris-Cité, F-75205, Paris, France.,AP-HP, Hôpital Bichat Claude-Bernard, service de médecine interne, 46 rue Henri-Huchard, 75018, Paris, France
| | - Karim Sacré
- Université Paris-Diderot, Sorbonne Paris-Cité, F-75205, Paris, France.,AP-HP, Hôpital Bichat Claude-Bernard, service de médecine interne, 46 rue Henri-Huchard, 75018, Paris, France
| | - Olivier Fain
- Sorbonne Université, Hôpital Saint Antoine, APHP, service de médecine interne, F 75012, Paris, France
| | - Jérôme Stirnemann
- Hôpitaux Universitaires de Genève, Service de Médecine interne Générale, Avenue Gabrielle Perret Gentil 4, CH-1211, Geneva, Switzerland
| | - Patrice Cacoub
- UPMC, Université Paris 6, Paris, France.,AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence maladies auto-immunes et systémiques rares, service de médecine interne 2, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Gaelle Leroux
- UPMC, Université Paris 6, Paris, France.,AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence maladies auto-immunes et systémiques rares, service de médecine interne 2, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Judith Cohen-Bittan
- AP-HP, Hôpital Pitié-Salpêtrière, service de gériatrie, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Jérémie Sellam
- AP-HP, Hôpital Saint Antoine, Service de Rhumatologie, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France
| | - Xavier Mariette
- Service de Rhumatologie, Hôpitaux Universitaires Paris-Sud, AP-HP, Université Paris-Sud, INSERM UMR 1184, Paris, France
| | - Claire Goulvestre
- AP-HP, Hôpital Cochin, service d'immunologie biologique, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France
| | | | - Zahir Amoura
- UPMC, Université Paris 6, Paris, France.,AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence pour le Lupus Systémique et le syndrome des Antiphospholipides, service de médecine interne, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | - Michel Vidal
- AP-HP, Hôpital Cochin, Biologie du médicament - Toxicologie, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France.,UMR8038 CNRS, U1268 INSERM, Faculty of Pharmacy, University Paris Descartes, PRES Sorbonne Paris Cité, Paris, France
| | - Jean-Charles Piette
- UPMC, Université Paris 6, Paris, France.,AP-HP, Hôpital Pitié-Salpêtrière, Centre de référence maladies auto-immunes et systémiques rares, service de médecine interne 2, 47-83 Boulevard de l'Hôpital, 75651, Paris Cedex 13, France
| | | | - Noémie Jourde-Chiche
- Aix-Marseille Univ, C2VN, INSERM 1263, INRA 1260 ; AP-HM, Centre de Néphrologie et Transplantation Rénale, Marseille, France
| | - Nathalie Costedoat-Chalumeau
- AP-HP, Hôpital Cochin, Centre de référence maladies auto-immunes et systémiques rares, service de médecine interne, 27 rue du Faubourg Saint-Jacques, 75014, Paris, France. .,Université Paris-Descartes, Paris, France. .,INSERM U 1153, Center for Epidemiology and Statistics Sorbonne Paris Cité (CRESS), Paris, France.
| |
Collapse
|
13
|
Salle V, Gomila C, Diouf M, Schmidt J, Galmiche A, Conte M, Smail A, Boulu X, Morel P, Marolleau J, Dersigny A, Herpe Y, Duhaut P. Dosage de l’annexine A2 au cours du myélome multiple. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
14
|
Aubignat M, Smail A, Schmidt J, Salle V, Sevestre H, Duhaut P. Tumeurs brunes pelviennes : évolution sur 12 ans. Rev Med Interne 2019. [DOI: 10.1016/j.revmed.2019.10.222] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
15
|
Alix L, Néel A, Cador B, Smail A, Serratrice J, Closs-Prophette F, Jego P, Devillers A, Decaux O. Diagnostic value of 18-F fluorodeoxyglucose PET/CT and bone scan in Schnitzler syndrome. Autoimmunity 2019; 52:264-271. [PMID: 31646899 DOI: 10.1080/08916934.2019.1680649] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Abstract
Introduction: Schnitzler syndrome is an auto-inflammatory disease defined by chronic urticarial eruption and monoclonal gammopathy. 18F fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is often performed, but its utility in Schnitzler syndrome has not been specifically investigated. The aim of this study was to determine whether PET/CT is informative in the diagnosis and follow-up of Schnitzler syndrome relative to other imaging techniques, including bone scans.Patients and methods: Patients of this study were selected from the French cohort established by Néel et al. All patients with a diagnosis of Schnitzler syndrome (according to Strasbourg's and Lipsker's criteria) who had at least one PET/CT were included. Data were collected from medical records. PET/CT scans were all reviewed by a nuclear physician blinded to the clinical and imaging data.Results: Ten patients underwent at least one PET/CT scan and all had at least one 99mTechnetium bone scan during their follow-up. The most frequent PET/CT abnormalities were diffuse bone-marrow and/or increased femoral fluorodeoxyglucose uptake, but they did not correlate with disease activity. Conversely, bone-scan abnormalities, including mainly increased radiotracer uptake in long bones, appeared to strongly correlate with Schnitzler syndrome activity.Discussion: PET/CT does not appear to be useful for the diagnosis and follow-up of Schnitzler syndrome. However, bone scans appear to be more sensitive for diagnosis and may correlate with clinical activity. Bone scans may be well positioned to distinguish Schnitzler syndrome relapse from other aetiologies of bone, joint, or muscle pain.Conclusion: Bone scans may be favoured over PET/CT in Schnitzler syndrome.
Collapse
Affiliation(s)
- L Alix
- Internal Medicine Department, Rennes University Hospital, Rennes, France
| | - A Néel
- Internal Medicine Department, Nantes University Hospital, Nantes, France
| | - B Cador
- Internal Medicine Department, Rennes University Hospital, Rennes, France
| | - A Smail
- Internal Medicine Department, Amiens University Hospital, Amiens, France
| | - J Serratrice
- Internal Medicine Department, Geneva University Hospital, Geneva, Switzerland
| | | | - P Jego
- Internal Medicine Department, Rennes University Hospital, Rennes, France
| | - A Devillers
- Nuclear Medicine Department, Regional Center for the Fight against Cancer, Rennes, France
| | - O Decaux
- Internal Medicine Department, Rennes University Hospital, Rennes, France
| |
Collapse
|
16
|
Salle V, Sagnier A, Diouf M, Schmidt J, Smail A, Galmiche A, Herpe Y, Duhaut P. Prevalence of anti-S100A10 antibodies in antiphospholipid syndrome patients. Thromb Res 2019; 179:15-19. [DOI: 10.1016/j.thromres.2019.04.027] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2019] [Revised: 04/19/2019] [Accepted: 04/23/2019] [Indexed: 12/24/2022]
|
17
|
Aubignat M, Smail A, Merle PE, Salle V, Schmidt J, Duhaut P. Sclérose Latérale Amyotrophique et hépatite C chronique : coïncidence ou complication neurologique de l’infection ? Rev Neurol (Paris) 2019. [DOI: 10.1016/j.neurol.2019.01.135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
18
|
Lanoix JP, El Samad Y, Schmit JL, Legrain A, Joseph C, Smail A, Douadi C, Adjidé C, Merlin-Brochart J, Couvreur V. Effect Of Motivational Team On Influenza Vaccination Coverage Among Health Care Workers. Infect Dis (Lond) 2019; 51:302-304. [PMID: 30676810 DOI: 10.1080/23744235.2018.1548774] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Affiliation(s)
- Jean-Philippe Lanoix
- a Department of Infectious Diseases , University Hospital of Amiens-Picardie , Amiens , France
| | - Youssef El Samad
- a Department of Infectious Diseases , University Hospital of Amiens-Picardie , Amiens , France
| | - Jean-Luc Schmit
- a Department of Infectious Diseases , University Hospital of Amiens-Picardie , Amiens , France
| | - Agathe Legrain
- a Department of Infectious Diseases , University Hospital of Amiens-Picardie , Amiens , France
| | - Cédric Joseph
- a Department of Infectious Diseases , University Hospital of Amiens-Picardie , Amiens , France
| | - Amar Smail
- b Department of Internal Medicine , University Hospital of Amiens-Picardie , Amiens , France
| | - Céline Douadi
- a Department of Infectious Diseases , University Hospital of Amiens-Picardie , Amiens , France
| | - Crespin Adjidé
- c Department of Hygiene , University Hospital of Amiens-Picardie , Amiens , France
| | | | - Virginie Couvreur
- d Department of Occupational Health , University Hospital of Amiens-Picardie , Amiens , France
| |
Collapse
|
19
|
Smail A, Fontaine N, Aubignat M, Brault C, Salle V, Schmidt J, Duhaut P. Rôle du médecin généraliste dans la prise en charge du patient sous corticothérapie per os au long cours : enquête de pratiques à propos de 95 cas. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.197] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
20
|
Metzelard M, Chaby G, Schmidt J, Duhaut P, Boulu X, Clement B, Lombart F, Ikoli J, Chatelain D, Baltazard T, Smail A, Salle V. Association psoriasis et syndrome Sjögren-like : quand la pathologie inflammatoire rencontre la pathologie auto-immune, nouvelle entité ou association fortuite ? Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.10.067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
21
|
Gourguechon C, Salle V, Brault C, Schmidt J, Karam J, Boulu X, Constans J, Sevestre H, Pater F, Galicier L, Duhaut P, Smail A. Efficacité du traitement par abatacept sur l’atteinte cérébrale cortico-dépendante secondaire à un déficit en CTLA-4. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.166] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
22
|
Aubignat M, Schmidt J, Gourguechon C, Brault C, Salle V, Smail A, Duhaut P. Myopathies à anticorps anti-HMGCR : à propos de 5 cas. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.225] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
23
|
Aubignat M, Schmidt J, Salle V, Smail A, Duhaut P. Les myopathies à anticorps anti-HMGCR en 2018 : état des lieux des connaissances. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
24
|
Boulu X, Meyer M, Smail A, Salle V, Pater F, Duhaut P, Schmidt J. Rentabilité diagnostique du TEP/CT dans l’exploration d’un syndrome inflammatoire prolongé inexpliqué : à propos de 144 patients. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.311] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
25
|
Duhaut P, Smail A, Salle V, Pater F, Brault C, Schmidt J. Consultations dans un service de médecine interne et aspects médico-économiques. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.274] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
26
|
Aubignat M, Dernoncourt A, Gourguechon C, Schmidt J, Salle V, Smail A, Canaple S, Sevestre H, Duhaut P. Myopathie à anticorps anti-HMGCR associée à une méningite lymphocytaire et des anticorps anti-gangliosides et anti-sulfatides. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
27
|
Aubignat M, Salle V, Gourguechon C, Smail A, Schmidt J, Sevestre H, Merle P, Duhaut P. Neuropathie motrice et ichtyose paranéoplasiques révélant un lymphome de Hodgkin. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
28
|
Aubignat M, Salle V, Schmidt J, Smail A, Sevestre H, Merle P, Duhaut P. Neuropathie motrice et ichtyose paranéoplasiques révélant un lymphome de Hodgkin. Rev Neurol (Paris) 2018. [DOI: 10.1016/j.neurol.2018.01.324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
29
|
Aubignat M, Gourguechon C, Schmidt J, Salle V, Smail A, Sevestre H, Duhaut P. Lymphome intravasculaire ou vascularite cérébrale ? Un défi diagnostique et une question vitale. Rev Neurol (Paris) 2018. [DOI: 10.1016/j.neurol.2018.01.173] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
30
|
Pater F, Delbarre M, Schmidt J, Salle V, Smail A, Gourguechon C, Duhaut P. Une sclérose latérale primitive/amyotrophique réversible ou le syndrome du moine copiste. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.209] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
31
|
Aubignat M, Smail A, Salle V, Gourguechon C, Schmidt J, Duhaut P. Panniculite des cavaliers associés au froid (perniose des cavaliers) : à propos d’un cas. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
32
|
Aubignat M, Schmidt J, Smail A, Salle V, Gourguechon C, Pater F, Duhaut P. Pathologies neuromusculaires et profession d’agriculteur : étude castémoins en milieu hospitalier. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.355] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
33
|
Salle V, Schmidt J, Delbarre M, Gourguechon C, Pater F, Smail A, Duhaut P. Activité agricole et cancers hématologiques : étude cas-témoins dans un service de médecine interne. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
34
|
Salle V, Schmidt J, Aubignat M, Galmiche A, Dernoncourt A, Smail A, Brulé A, Delbarre M, Gourguechon C, Pater F, Herpe Y, Duhaut P. Anticorps dirigés contre la protéine S100A10 au cours du syndrome des antiphospholipides. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.090] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
35
|
Aubignat M, Karam J, Schmidt J, Salle V, Smail A, Sevestre H, Duhaut P. Lymphome intravasculaire ou vascularite cérébrale ? Un défi diagnostique et une question vitale. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
36
|
Fournier A, Sultan A, Morello R, Hachulla E, Smail A, Verdon R, Launay O, Guillevin L, Bienvenu B, Marchand-Janssen C. DTPID : comment sont vaccinés les patients atteints d’une maladie inflammatoire systémique ? Med Mal Infect 2017. [DOI: 10.1016/j.medmal.2017.03.307] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
37
|
Florentina P, Schmidt J, Dernoncourt A, Salle V, Gourguechon C, Smail A, Duhaut P. Agriculteurs et risque de cancers : étude cas-témoins prospective. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.03.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
38
|
Roca F, Dominique S, Schmidt J, Smail A, Duhaut P, Lévesque H, Marie I. Interstitial lung disease in primary Sjögren's syndrome. Autoimmun Rev 2017; 16:48-54. [DOI: 10.1016/j.autrev.2016.09.017] [Citation(s) in RCA: 88] [Impact Index Per Article: 12.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2016] [Accepted: 08/08/2016] [Indexed: 12/21/2022]
|
39
|
Kleinmann J, Tubach F, Le Guern V, Mathian A, Richez C, Saadoun D, Sacré K, Sellam J, Seror R, Amoura Z, Andres E, Audia S, Bader-Meunier B, Blaison G, Bonnotte B, Cacoub P, Caillard S, Chiche L, Chosidow O, Costedoat-Chalumeau N, Daien C, Daugas E, Derdèche N, Doria A, Fain O, Fakhouri F, Farge D, Gabay C, Guillo S, Hachulla E, Hajjaj-Hassouni N, Hamidou M, Houssiau F, Jourde-Chiche N, Kone-Paut I, Ladjouz-Rezig A, Lambotte O, Lipsker D, Mariette X, Martin Silva N, Martin T, Maurier F, Meckenstock R, Mekinian A, Meyer O, Mohamed S, Morel J, Moulin B, Mulleman D, Papo T, Poindron V, Puéchal X, Punzi L, Quartier P, Sailler L, Smail A, Soubrier M, Sparsa A, Tazi Mezalek Z, Zakraoui L, Zuily S, Sibilia J, Gottenberg J. Recommandations francophones, internationales et multidisciplinaires d’experts pour l’utilisation de biomédicaments dans le lupus érythémateux systémique : le groupe de travail du CRI-IMIDIATE. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
40
|
Sagnier A, Salle V, Schmidt J, Gourguechon C, Karam JD, Boulu X, Smail A, Metzelard M, Pater F, Duhaut P. Amylose AA et nodule thyroïdien : penser au cancer médullaire de la thyroïde ! Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.10.322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
41
|
Salle V, Schmidt J, Smail A, Mazière C, Conte MA, Brulé A, Mazière JC, Cadet E, Herpe YE, Duhaut P. Antibodies directed against annexin A2 and obstetric morbidity. J Reprod Immunol 2016; 118:50-53. [PMID: 27631133 DOI: 10.1016/j.jri.2016.08.010] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2016] [Revised: 08/25/2016] [Accepted: 08/29/2016] [Indexed: 01/11/2023]
Abstract
Acquired and inherited thrombophilia have both been reported to be associated with an increased risk of obstetric complications in early or later stages of pregnancy. Annexin A2 (ANXA2) is strongly expressed in vascular and placental tissues and plays a crucial role in fibrinolysis. The aim of the present study was to evaluate the prevalence of antibodies directed against ANXA2 in patients with recurrent miscarriage or obstetric complications. Anti-ANXA2 antibodies (aANXA2) were detected by ELISA in the sera from 46 women with obstetric morbidity, mainly recurrent miscarriage. The cut-off value for positivity was defined as 3 standard deviations above the mean optical density (OD) obtained in the sera from 42 female blood donors. The prevalence of aANXA2 in patients and healthy individuals was 15.2% and 2.3%, respectively. A statistically significant difference was observed between the 2 groups in terms of aANXA2 IgG titers (p=0.01). The highest aANXA2 levels were observed in sera from 2 patients with recurrent miscarriage and one patient with preeclampsia. aANXA2 could play a role in thrombotic mechanisms leading to recurrent pregnancy loss and placental vascular disease. Further studies are needed to determine whether ANXA2 is critical for maintenance of placental integrity.
Collapse
Affiliation(s)
- V Salle
- Department of Internal Medicine, Amiens University Hospital, France; INSERM U1088, Biochemistry Laboratory, Amiens University Hospital, France.
| | - J Schmidt
- Department of Internal Medicine, Amiens University Hospital, France
| | - A Smail
- Department of Internal Medicine, Amiens University Hospital, France
| | - C Mazière
- INSERM U1088, Biochemistry Laboratory, Amiens University Hospital, France
| | - M A Conte
- INSERM U1088, Biochemistry Laboratory, Amiens University Hospital, France
| | - A Brulé
- French Blood Establishment-North of France, France
| | - J C Mazière
- INSERM U1088, Biochemistry Laboratory, Amiens University Hospital, France
| | - E Cadet
- Department of Genetics, Amiens University Hospital, France
| | - Y E Herpe
- Biobank of Picardie, Amiens University Hospital, Amiens, France
| | - P Duhaut
- Department of Internal Medicine, Amiens University Hospital, France
| |
Collapse
|
42
|
Puéchal X, Pagnoux C, Perrodeau É, Hamidou M, Boffa JJ, Kyndt X, Lifermann F, Papo T, Merrien D, Smail A, Delaval P, Hanrotel-Saliou C, Imbert B, Khouatra C, Lambert M, Leské C, Ly KH, Pertuiset E, Roblot P, Ruivard M, Subra JF, Viallard JF, Terrier B, Cohen P, Mouthon L, Le Jeunne C, Ravaud P, Guillevin L. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis. Arthritis Rheumatol 2016; 68:690-701. [PMID: 26473755 DOI: 10.1002/art.39450] [Citation(s) in RCA: 84] [Impact Index Per Article: 10.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2015] [Accepted: 09/24/2015] [Indexed: 12/13/2022]
Abstract
OBJECTIVE Findings from the WEGENT trial and other short-term studies have suggested that azathioprine (AZA) or methotrexate (MTX) could effectively maintain remission of granulomatosis with polyangiitis (Wegener's) (GPA) or microscopic polyangiitis (MPA). This study was undertaken to examine whether differences in rates of relapse or adverse events would appear after discontinuation of these 2 maintenance regimens, when assessed over a longer followup period. METHODS Long-term outcomes in patients enrolled in the WEGENT trial were analyzed according to their randomized treatment group (AZA or MTX). Parameters at trial entry were evaluated as potential prognostic factors for death, relapse, or damage in multivariate models. RESULTS Data from 10 years of followup were available for 112 (88.8%) of the 126 original trial participants. The median followup time was 11.9 years (95% confidence interval [95% CI] 11.3-12.5 years). In patients receiving AZA and those receiving MTX, the 10-year overall survival rates were 75.1% (95% CI 64.8-86.9%) and 79.9% (95% CI 70.3-90.8%) (P = 0.56), respectively, and relapse-free survival rates were 26.3% (95% CI 17.3-40.1%) and 33.5% (95% CI 23.5-47.7%) (P = 0.29), respectively. No between-treatment differences were observed with regard to rates of relapse, adverse events, damage, survival without severe side effects, and survival without relapse and severe side effects. In analyses limited to the 97 patients with GPA, no between-treatment differences in survival rates were observed. The 10-year relapse-free survival rate was lower in patients with GPA than in patients with MPA. However, in the multivariate analysis, anti-proteinase 3 antineutrophil cytoplasmic antibody (ANCA) positivity, and not GPA, was retained as being independently associated with the relapse rate. CONCLUSION The results of this long-term analysis confirm that AZA and MTX are comparable treatment options for maintaining remission of GPA or MPA. Despite achieving good overall survival with these treatments, relapse rates, adverse events, and damage remain matters of concern and further studies are needed to reduce their frequency in these ANCA-associated vasculitides.
Collapse
Affiliation(s)
- Xavier Puéchal
- Université Paris Descartes and Hôpital Cochin, AP-HP, Paris, France
| | | | | | | | | | - Xavier Kyndt
- Centre Hospitalier de Valenciennes, Valenciennes, France
| | | | - Thomas Papo
- Hôpital Bichat-Claude Bernard, Paris, France
| | | | | | | | | | - Bernard Imbert
- Centre Hospitalier Universitaire de Grenoble, Grenoble, France
| | | | - Marc Lambert
- Centre Hospitalier Régional Universitaire de Lille, Lille, France
| | | | - Kim H Ly
- Hôpital Dupuytren, Limoges, France
| | | | - Pascal Roblot
- Centre Hospitalier Universitaire de Poitiers, Poitiers, France
| | | | | | | | - Benjamin Terrier
- Université Paris Descartes and Hôpital Cochin, AP-HP, Paris, France
| | - Pascal Cohen
- Université Paris Descartes and Hôpital Cochin, AP-HP, Paris, France
| | - Luc Mouthon
- Université Paris Descartes and Hôpital Cochin, AP-HP, Paris, France
| | - Claire Le Jeunne
- Université Paris Descartes and Hôpital Cochin, AP-HP, Paris, France
| | | | - Loïc Guillevin
- Université Paris Descartes and Hôpital Cochin, AP-HP, Paris, France
| | | |
Collapse
|
43
|
Karam J, Gourguechon C, Lacroix M, Brault C, Schmidt J, Pater F, Smail A, Salle V, Duhaut P. Thrombose veineuse abdominale et prise de créatine à but sportif : une association fortuite ? Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
44
|
Ullmer A, Karam J, Gourguechon C, Pater F, Schmidt J, Duhaut P, Brault C, Smail A, Salle V. Maladie de Rendu-Osler et myélome multiple : une dangereuse association compliquant la prise en charge de l’hémopathie. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
45
|
Gourguechon C, Le Roy G, Schmidt J, Brault C, Smail A, Salle V, Duhaut P. Association myasthénie auto-immune et maladie de Crohn : diagnostic au cours de la grossesse orienté par la biopsie de glandes salivaires accessoires. Rev Med Interne 2016. [DOI: 10.1016/j.revmed.2016.04.116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
46
|
Jolly M, Galicier L, Aumaître O, Francès C, Le Guern V, Lioté F, Smail A, Limal N, Perard L, Desmurs-Clavel H, Boutin DLTH, Asli B, Kahn JE, Pourrat J, Sailler L, Ackermann F, Papo T, Sacré K, Fain O, Stirnemann J, Cacoub P, Jallouli M, Leroux G, Cohen-Bittan J, Hulot JS, Arora S, Amoura Z, Piette JC, Costedoat-Chalumeau N. Quality of life in systemic lupus erythematosus: description in a cohort of French patients and association with blood hydroxychloroquine levels. Lupus 2016; 25:735-740. [DOI: 10.1177/0961203315627200] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 08/30/2023]
Abstract
Objectives Benefits of hydroxychloroquine (HCQ) use on physician reported outcomes are well documented in systemic lupus erythematosus (SLE). We assess for the first time the association and predictive value of blood HCQ levels towards health-related quality of life (HRQOL) in SLE. Methods Data from the PLUS study (a randomized, double-blind, placebo-controlled, multicentre study) were utilized. Blood HCQ levels were quantified by high-performance liquid chromatography along with HRQOL assessments (Medical Outcomes Study-SF-36) at baseline (V1) and month 7 (V2). Results 166 SLE patients’ data were analysed. Mean (SD) age and disease duration were 44.4 (10.7) and 9.3 (6.8) years. Eighty-seven per cent were women. Mean (SD, median, IQR) HCQ concentrations in the blood at V1 were 660 (314, 615, 424) ng/ml and increased to 1020 (632, 906, 781) ng/ml at V2 (mean difference 366 units, 95% confidence interval −472 to −260, p < 0.001). No significant correlations between HCQ concentrations with HRQOL domains at V1 or V2 were noted. There were no differences in HRQOL stratified by HCQ concentrations. HCQ concentrations at V1 or changes in HCQ concentration (V2-V1) were not predictive of HRQOL at V2 or changes in HRQOL (V2-V1). Conclusions No association of HCQ concentrations with current or longitudinal HRQOL were found in SLE.
Collapse
Affiliation(s)
- M Jolly
- Rush University Medical Center, Chicago, IL, USA
| | - L Galicier
- Université Paris Diderot, Sorbonne Paris-Cité and AP-HP, Hôpital Saint Louis, service d’immunologie clinique, Paris, France
| | - O Aumaître
- Université de Clermont-Ferrand and CHU Clermont-Ferrand, Hôpital Gabriel Montpied, service de médecine interne, Clermont-Ferrand, France
| | - C Francès
- UPMC, Université Paris 6 and AP-HP, Hôpital Tenon, service de dermatologie allergologie, Paris, France
| | - V Le Guern
- Université Paris-Decartes and AP-HP, Hôpital Cochin, service de médecine interne, Paris, France
| | - F Lioté
- Université Paris-Diderot, Sorbonne Paris-Cité and AP-HP, Hôpital Lariboisière, service de rhumatologie, Paris, France
| | - A Smail
- CHU Amiens, Hôpital Nord, service de médecine interne, Amiens, France
| | - N Limal
- UPEC; AP-HP, Hôpital Henri Mondor, service de médecine interne, Créteil, France
| | - L Perard
- Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, service de médecine interne, Lyon, France
| | - H Desmurs-Clavel
- Hospices Civils de Lyon, Groupement Hospitalier Edouard Herriot, service de médecine interne, Lyon, France
| | - D L T H Boutin
- UPMC, Université Paris 6 and AP-HP, Hôpital Pitié-Salpêtrière, service de médecine interne, Paris, France
| | - B Asli
- Université Paris Diderot, Sorbonne Paris-Cité and AP-HP, Hôpital Saint Louis, service d’immunologie clinique, Paris, France
| | - J-E Kahn
- Hôpital Foch, service de médecine interne, Suresnes, France
| | - J Pourrat
- Université Paul-Sabatier and CHU Toulouse, Hôpital Rangueil, service de néphrologie, Toulouse, France
| | - L Sailler
- Université Paul-Sabatier and CHU Toulouse, Hôpital Purpan, service de médecine interne, Toulouse, France
| | - F Ackermann
- Hôpital Foch, service de médecine interne, Suresnes, France
| | - T Papo
- Université Paris-Diderot, Sorbonne Paris-Cité and AP-HP, Hôpital Bichat Claude-Bernard, service de médecine interne, Paris, France
| | - K Sacré
- Université Paris-Diderot, Sorbonne Paris-Cité and AP-HP, Hôpital Bichat Claude-Bernard, service de médecine interne, Paris, France
| | - O Fain
- Hôpital Saint Antoine, DHU i2B, service de médecine interne, Université Paris 6
| | - J Stirnemann
- Division of General Internal Medicine, Geneva University Hospital, Geneva, Switzerland
| | - P Cacoub
- APHP, Département de Médecine Interne et Immunologie clinique, Groupe Hospitalier Pitié Salpétriére Paris, France; DHU Inflammation, Immunopathologie, Biothérapie, Université Pierre et Marie Curie, Paris VI, France; UMR 7211 (UPMC/CNRS), UMR S-959 (INSERM)
| | - M Jallouli
- Université Paris-Decartes and AP-HP, Hôpital Cochin, service de médecine interne, Paris, France
| | - G Leroux
- UPMC, Université Paris 6 and AP-HP, Hôpital Pitié-Salpêtrière, service de médecine interne, Paris, France
| | - J Cohen-Bittan
- UPMC, Université Paris 6 and AP-HP, Hôpital Pitié-Salpêtrière, service de gériatrie Pr Verny, Paris, France
| | - J-S Hulot
- Sorbonne Universités, UPMC Univ Paris 06, AP-HP, Institute of Cardiometabolism and Nutrition (ICAN), F-75013, Paris, France
| | - S Arora
- Rush University Medical Center, Chicago, IL, USA
| | - Z Amoura
- UPMC, Université Paris 6 and AP-HP, Hôpital Pitié-Salpêtrière, service de médecine interne, Paris, France
| | - J-C Piette
- UPMC, Université Paris 6 and AP-HP, Hôpital Pitié-Salpêtrière, service de médecine interne, Paris, France
| | - N Costedoat-Chalumeau
- Université Paris-Decartes and AP-HP, Hôpital Cochin, service de médecine interne, Paris, France
| | | |
Collapse
|
47
|
Schmidt J, Smail A, Roche B, Gay P, Salle V, Pellet H, Duhaut P. Incidence of Severe Infections and Infection-Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double-Cohort Study. Arthritis Rheumatol 2016; 68:1477-82. [DOI: 10.1002/art.39596] [Citation(s) in RCA: 51] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2015] [Accepted: 01/12/2016] [Indexed: 11/08/2022]
Affiliation(s)
- J. Schmidt
- Amiens University Hospital and Jules Verne University of Picardy; INSERM U-1088 Amiens France
| | - A. Smail
- Amiens University Hospital; Amiens France
| | - B. Roche
- Filieris Medical Center; Saint-Étienne France
| | - P. Gay
- Filieris Medical Center; Saint-Étienne France
| | - V. Salle
- Amiens University Hospital and Jules Verne University of Picardy; INSERM U-1088 Amiens France
| | | | - P. Duhaut
- Amiens University Hospital and Jules Verne University of Picardy; INSERM U-1088 Amiens France
| |
Collapse
|
48
|
Houx L, Hachulla E, Kone-Paut I, Quartier P, Touitou I, Guennoc X, Grateau G, Hamidou M, Neven B, Berthelot JM, Lequerré T, Pillet P, Lemelle I, Fischbach M, Duquesne A, Le Blay P, Le Jeunne C, Stirnemann J, Bonnet C, Gaillard D, Alix L, Touraine R, Garcier F, Bedane C, Jurquet AL, Duffau P, Smail A, Frances C, Grall-Lerosey M, Cathebras P, Tran TA, Morell-Dubois S, Pagnier A, Richez C, Cuisset L, Devauchelle-Pensec V. Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study. Arthritis Rheumatol 2016; 67:3027-36. [PMID: 26245507 DOI: 10.1002/art.39292] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/28/2014] [Accepted: 07/16/2015] [Indexed: 11/05/2022]
Abstract
OBJECTIVE To determine the type and frequency of musculoskeletal symptoms at onset and during followup of cryopyrin-associated periodic syndromes (CAPS). METHODS We retrospectively recorded the articular and muscular symptoms of patients with CAPS followed up in French hospitals. Data were presented as frequencies or the median (range), and patient groups were compared using chi-square test, Fisher's exact test, and Mann-Whitney test. RESULTS The study included 133 patients (33 children), 20 with familial cold autoinflammatory syndrome, 88 with Muckle-Wells syndrome, 22 with chronic infantile neurologic, cutaneous, articular syndrome, and 3 with unclassified CAPS. The median age was 35 years (range 0-78 years) at the time of the study, 1 year (range 0-41 years) at symptom onset, and 23 years (range 0-58 years) at diagnosis. The disease was sporadic in 17% of the patients. Cutaneous symptoms predominated at onset (77%), followed by articular symptoms (30%). The p.Thr348Met and p.Arg260Trp NLRP3 mutations were significantly associated with the presence and absence of articular symptoms at onset, respectively. During followup, 86% of the patients had musculoskeletal symptoms, 88% had arthralgia, and 58% had arthritis, but only 9% had joint destruction. Tendinopathies occurred in 21.5% of the patients, tender points in 16.5%, and myalgia in 33%. Only 3 patients had typical knee deformities. Radiographs were rarely obtained. Except for bone deformities, osteoarticular symptoms occurred at similar frequencies in the different CAPS phenotypes. CONCLUSION Joint manifestations were frequent in all CAPS phenotypes. Bone deformities were rare. Musculoskeletal manifestations varied within given families but tended to worsen over time.
Collapse
Affiliation(s)
| | - Eric Hachulla
- Nord-de-France University and Claude-Huriez University Hospital, Lille, France
| | | | - Pierre Quartier
- Necker-Enfants Malades University Hospital and Paris Descartes University, Paris, France
| | | | | | - Gilles Grateau
- Tenon University Hospital, AP-HP, and Paris VI Pierre et Marie Curie University, Paris, France
| | | | - Bénédicte Neven
- Necker-Enfants Malades University Hospital, AP-HP, and INSERM U768 Laboratory, Paris, France
| | | | | | - Pascal Pillet
- Pellegrin-Enfants University Hospital, Bordeaux, France
| | | | | | - Agnès Duquesne
- Women-Mothers-Children University Hospital, Lyon, France
| | | | | | - Jérome Stirnemann
- Jean Verdier University Hospital, AP-HP, Paris XIII University, Paris, France
| | | | | | | | | | | | | | | | - Pierre Duffau
- Saint André Hospital, and Bordeaux University Hospital, Bordeaux, France
| | - Amar Smail
- North University Hospital, Amiens, France
| | | | | | | | | | | | | | | | - Laurence Cuisset
- Cochin Institute and University Hospital, AP-HP, Paris Descartes University, Paris, France
| | | |
Collapse
|
49
|
Thill P, Salle V, Smail A, Schmidt J, Duhaut P. Une maladie de Horton se révélant être une amylose AL…. Rev Med Interne 2015. [DOI: 10.1016/j.revmed.2015.10.136] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
50
|
Fraison JB, Sève P, Dauphin C, Mahr A, Gomard-Mennesson E, Varron L, Pugnet G, Landron C, Roblot P, Oziol E, Chalhoub G, Galempoix JM, Humbert S, Humbert P, Sbidian E, Grange F, Bayrou O, Cathebras P, Morlat P, Epaulard O, Pavese P, Huong DLT, Zoulim A, Stankovic K, Bachelez H, Smail A, Bachmeyer C, Granel B, Serratrice J, Brinchault G, Mekinian A, Costedoat-Chalumeau N, Bourgarit-Durand A, Puéchal X, Guillevin L, Piram M, Koné-Paut I, Fain O. Kawasaki disease in adults: Observations in France and literature review. Autoimmun Rev 2015; 15:242-9. [PMID: 26631821 DOI: 10.1016/j.autrev.2015.11.010] [Citation(s) in RCA: 44] [Impact Index Per Article: 4.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/04/2015] [Accepted: 11/20/2015] [Indexed: 12/29/2022]
Abstract
OBJECTIVE Kawasaki disease (KD) is a vasculitis that mostly occurs in young children and rarely in adults. We analyzed the characteristics of adult-onset KD (AKD) in France. METHODS We collected retrospective and prospective data for patients with a diagnosis of KD occurring after the age of 18 years. Cases were obtained via various French medical networks and identified from the international literature. RESULTS We included 43 patients of AKD at 26 institution from 1992 to 2015, with mean (SD) age 30 (11) years (range 18-68) and sex ratio (M/F) 1.2; 34 patients met the American Heart Association criteria and 9 were incomplete AKD. The median time to diagnosis was 13 days (interquartile range 8-21). The main symptoms were fever (100%), exanthema (98%), changes in the extremities (91%), conjunctivitis (77%), oral cavity changes (89%), cervical adenitis (55%) and cardiac abnormalities (45%). Overall, 35% of patients showed large-vessel vasculitis: coronary vasculitis (26%) and coronary aneurysm (19%). Treatment was mostly intravenous immunoglobulins (79%) and aspirin (81%). Four patients showed myocardial infarction due to coronary vasculitis, but none were treated with IVIg because of late diagnosis. After a median follow-up of 5 months (range 1-117), persistent aneurysm was noted in 9% of cases. Damage was significantly lower with early treatment than late or no treatment (p=0.01). CONCLUSION Given the high frequency of cardiac involvement and complications in this series of AKD, diagnosis and treatment should not be delayed, and early IVIg treatment seems to improve the outcome.
Collapse
Affiliation(s)
- Jean-Baptiste Fraison
- Service de Médecine Interne, Hôpital Saint Louis, AP HP, Université Diderot, France.
| | - Pascal Sève
- Service de Médecine Interne, Hôpital de la Croix Rousse, Centre Hospitalier Universitaire de Lyon, Université de Lyon, France
| | - Claire Dauphin
- Service de Cardiologie, Hôpital Gabriel Montpied, Université de Clermont-Ferrand, France
| | - Alfred Mahr
- Service de Médecine Interne, Hôpital Saint Louis, AP HP, Université Diderot, France
| | | | - Loig Varron
- Service de Médecine Interne, Centre Hospitalier de Montélimar, France
| | - Gregory Pugnet
- Service de Médecine Interne, Centre Hospitalier Universitaire de Toulouse, France
| | - Cédric Landron
- Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Poitiers, France
| | - Pascal Roblot
- Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Poitiers, France
| | - Eric Oziol
- Service de Médecine Interne, Centre Hospitalier de Béziers, France
| | - Gihane Chalhoub
- Service de Médecine Interne, Centre Hospitalier de Metz-Thionville, France
| | - Jean-Marc Galempoix
- Service de Médecine Interne, Centre Hospitalier de Charleville-Mézières, France
| | - Sébastien Humbert
- Service de Médecine Interne, Centre Hospitalier Universitaire de Besançon, France
| | - Philippe Humbert
- Service de Dermatologie, Centre Hospitalier Universitaire de Besançon, University of Franche-Comté, INSERM UMR1098, SFR FED 4234 IBCT, Besançon, France
| | - Emilie Sbidian
- Service de Dermatologie, Hôpital Henri Mondor, AP HP, Université Paris Est, France
| | - Florent Grange
- Service de Dermatologie, Centre Hospitalier Universitaire de Reims, France
| | - Olivier Bayrou
- Service de Dermatologie, Hôpital Tenon, AP HP, Université Pierre et Marie Curie, France
| | - Pascal Cathebras
- Service de Médecine Interne, Centre Hospitalier Universitaire de St Etienne, France
| | - Philippe Morlat
- Service de Médecine Interne et Maladies Infectieuses, Centre Hospitalier Universitaire de Bordeaux, France
| | - Olivier Epaulard
- Service de Maladies Infectieuses, Centre Hospitalier Universitaire de Grenoble, France
| | - Patricia Pavese
- Service de Maladies Infectieuses, Centre Hospitalier Universitaire de Grenoble, France
| | - Du Le Thi Huong
- Service de Médecine Interne 2, Hôpital La Pitié-Salpétrière, AP HP, Université Pierre et Marie Curie, France
| | - Abdelkader Zoulim
- Service de Médecine Interne, Centre Hospitalier Universitaire de Caen, France
| | - Katia Stankovic
- Service de Médecine Interne, Hôpital Tenon, AP HP, Université Pierre et Marie Curie, France
| | - Hervé Bachelez
- Service de Dermatologie, Hôpital Saint Louis, AP HP, Université Diderot, France
| | - Amar Smail
- Service de Médecine Interne, Centre Hospitalier Universitaire d'Amiens, France
| | - C Bachmeyer
- Service de Médecine Interne, Centre Hospitalier de Creil, France
| | | | | | | | - Arsène Mekinian
- Service de Médecine Interne, DHUi2B, Hôpital Saint Antoine, AP HP, Université Pierre et Marie Curie, France
| | - Nathalie Costedoat-Chalumeau
- Service de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies Systémiques et Autoimmunes Rares, AP HP, Université Paris Descartes, France
| | - Anne Bourgarit-Durand
- Service de Médecine Interne, Hôpital Jean Verdier, AP HP, Université Leonard de Vinci, France
| | - Xavier Puéchal
- Service de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies Systémiques et Autoimmunes Rares, AP HP, Université Paris Descartes, France
| | - Loïc Guillevin
- Service de Médecine Interne, Hôpital Cochin, Centre de Référence Maladies Systémiques et Autoimmunes Rares, AP HP, Université Paris Descartes, France
| | - Maryam Piram
- Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies Auto-Inflammatoires de l'enfant, Hôpital Bicêtre, AP HP, Université Paris Sud, France
| | - Isabelle Koné-Paut
- Service de Rhumatologie Pédiatrique, Centre de Référence des Maladies Auto-Inflammatoires de l'enfant, Hôpital Bicêtre, AP HP, Université Paris Sud, France
| | - Olivier Fain
- Service de Médecine Interne, DHUi2B, Hôpital Saint Antoine, AP HP, Université Pierre et Marie Curie, France
| | | |
Collapse
|